Spots Global Cancer Trial Database for Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study
Official Title: Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study
Study ID: NCT04429139
Conditions
Interventions
Study Description
Brief Summary: To study the effectiveness and safety profiles of photodynamic therapy (PDT) for the treatment of human retinoblastoma.
Detailed Description: Retinoblastoma is the commonest primary intraocular malignancy in infancy and early childhood. Ophthalmologist are trying to seek other more safe and effective treatment modalities to well control the tumor and preserve the visual function. Photodynamic therapy (PDT) is a potentially therapeutic approach for retinoblastoma which has been underestimated. In this study, we are gonging to investigate the the effectiveness and safety profiles of photodynamic therapy (PDT) for the treatment of human retinoblastoma.
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kunbei Lai, Guangzhou, Guangdong, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
